Schedule 13G ownership disclosure
Capricor Therapeutics Inc
Common Stock · CUSIP: 14070B309
Event date: 2025-03-31
- Filing-level shares
- 2,263,991
- Percent of class
- 4.95%
- The Vanguard Group
Shares: 2,263,991 · Class: 4.95%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000486
- Form type
- SCHEDULE 13G/A
- Filer
- CAPRICOR THERAPEUTICS, INC.
- CIK
- CIK 1133869
- Filed
- Apr 30, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership